Posted by Michael Wonder on 16 Jun 2020
First drug proves able to improve survival from COVID-19, trial shows
17 June 2020 - A low-cost, widely used anti-inflammatory drug has improved survival in patients with COVID-19, scientists say, the first treatment to show lifesaving promise months into the pandemic.
Researchers in England say the steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalised patients.
The results were announced on Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2104 patients to get the drug and compared them with 4321 patients getting only usual care.
